Some health experts view GLP-1s as a promising option for PCOS, which lacks a standard treatment and affects millions of ...

California pension fund CalPERS, the second-largest public purchaser of health benefits in the U.S., announced on Tuesday ...

A new study suggests that eating more protein while taking GLP-1 medications could help prevent muscle loss, a common side ...

CVS Caremark will stop covering Eli Lilly’s Zepbound. Wegovy, the GLP-1 medication to treat obesity from Lilly competitor ...

And they do so to a similar degree. In a 12-week study of active females from 2004, treadmill and StairMaster workouts both ...

Lawmakers are trying to restore access to GLP-1 weight loss drugs, like Ozempic and Wegovy, after Ohio removed medical ...

The launch of GLP-1 weight loss drugs in India is gaining popularity. Harvard researchers share a comprehensive guidance for ...

GLP-1 weight-loss drugs are changing how people date and connect. In a survey from the Kinsey Institute and DatingAdvice.com, 59% of GLP-1 users reported the drug had at least one side-effect on their ...

Over half of large US employers plan to cut health benefits in 2026 as rising costs of weight-loss drugs like Wegovy drive up ...

More than half of large employers plan to scale back health care benefits next year as rising costs from weight-loss and specialty drugs squeeze budgets, according to a new survey released by ...

Hims & Hers is pitching consumers on a GLP-1 weight loss injection that will cost 85% less than brand-name drugs like Wegovy.

Half of those surveyed plan to raise deductibles and maximum out-of-pocket costs for workers. Read more at straitstimes.com. Read more at straitstimes.com.